Hyloris Expands Cardiovascular Pipeline with Breakthrough Extended-Release Milrinone Capsule in ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Related Keywords

Australia ,Minnesota ,United States ,China ,Japan ,Melbourne ,Victoria ,Belgium ,American ,Marieke Vermeersch ,Stijn Van Rompay ,David Kaye ,Baker Institute ,American Heart Association ,Department Of Cardiology ,Linkedin ,Drug Designation Program ,York Heart Association ,Hyloris Pharmaceuticals ,View Research Inc ,Centers For Disease Control ,Diabetes Institute ,Diabetes Institute The Baker ,Head Of The Heart Failure Research Group ,Hyloris Pharmaceuticals Sa Euronext Brussels ,Corporate Communications ,Euronext Brussels ,Baker Heart ,Heart Failure Specialist ,Heart Failure Research Group ,Alfred Hospital ,Van Rompay ,Chief Executive Officer ,Minnesota Living ,Heart Failure Score ,Heart Failure ,American Journal ,New York Heart Association ,Disease Control ,Heart Disease ,Stroke Statistics ,Thoratic Disease ,View Research ,Triangle Insights ,Business ,Hyloris Pharmaceuticals Sa ,Medication ,Health ,Intellectual Property ,Globe Newswire ,Diabetes ,